First-Line Extensive-Stage SCLC: Examining the New Role of Combination Chemotherapy and Immunotherapy

First-Line Extensive-Stage SCLC: Examining the New Role of Combination Chemotherapy and Immunotherapy

Episodes

Specialty:

All

Year:

All

EP. 1: Background of Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 2: Differentiating Small Cell Lung Cancer and Non-Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 3: Aggressive Nature of Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 4: Rationale for I/O therapy in Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 5: Advances in Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 6: Results from the IMpower133 Trial for Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 7: Results from the CASPIAN Trial for Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 8: First-Line Approach for Treating Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 9: Treatment After Progression on Front-Line Therapy in Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

EP. 10: Ongoing Research in Extensive-Stage Small Cell Lung Cancer

ByKathryn Gold, MD, UC San Diego Health,Konstantinos Leventakos, MD, PhD Mayo Clinic ,Taofeek K. Owonikoko, MD, PhD; UPMC Hillman Cancer Center

December 11th 2020

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

Harold P. Freeman, MD, Pioneer of Patient Navigation and Cancer Disparities Research, Dies at 93